Literature DB >> 35266007

Caregiving, Participation, and Quality of Life of Closest Next of Kin of Persons Living with Spinal Cord Injury in Norway.

Annette Halvorsen1, Kristine Pape, Marcel Post, Fin Biering-Sørensen, Monica Engelsjord, Aslak Steinsbekk.   

Abstract

OBJECTIVES: To investigate how next of kin of persons with spinal cord injury (SCI) experience various life areas in terms of caregiving, participation, and quality of life, and the impact of personal characteristics of next of kin and SCI characteristics.
DESIGN: Survey of next of kin linked to data on persons with SCI in the Norwegian SCI Registry. PARTICIPANTS: A total of 73 next of kin identified by persons with SCI.
METHODS: Outcome measures were caregiving (4 measures), participation (1 measure), and quality of life (2 measures).
RESULTS: Participants (73% partners, 73% female, mean age 56.4 years) gave various support to the person with SCI and considered it important to care and were happy to do so. Three-quarters of participants reported good mental health and life satisfaction, while one-quarter reported high levels of caregiver strain, especially related to emotional adjustments. Higher levels of caregiver strain were reported by participants of working age (< 67 years), and by those with middle level education.
CONCLUSION: The majority of next of kin of persons living with SCI in Norway are doing well in most life areas. Caregiver strain may be reduced by strengthening the ability of next of kin to cope with emotional challenges.

Entities:  

Mesh:

Year:  2022        PMID: 35266007     DOI: 10.2340/jrm.v54.2162

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  1 in total

1.  Caregivers' Knowledge, Attitude, and Practice towards Pressure Injuries in Spinal Cord Injury at Rehabilitation Center in Bangladesh.

Authors:  Niraj Singh Tharu; Monzurul Alam; Shristi Bajracharya; Gautam Prasad Chaudhary; Jitendra Pandey; Mohammad A Kabir
Journal:  Adv Orthop       Date:  2022-06-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.